Axonyx Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

  • Investments
  • 3

Axonyx General Information

Description

Operator of a biopharmaceutical company. The company's activities include acquisition and development of proprietary pharmaceutical compounds and new technologies useful in the diagnosis and treatment of Alzheimer's disease, human memory disorders and prion-based illnesses such as Mad Cow Disease.

Contact Information

Website
www.axonyx.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 500 Seventh Avenue
  • 10th floor
  • New York, NY 10018
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
TorreyPines Therapeutics
Corporate Office
  • 500 Seventh Avenue
  • 10th floor
  • New York, NY 10018
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axonyx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Axonyx‘s full profile, request access.

Request a free trial

Axonyx Patents

  • 79

    Total Documents Applications and Grants

  • Total Patents Families

  • 17

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Axonyx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2025512425-A Neurostimulation lead placement systems and methods Pending 15-Apr-2022
JP-2025501312-A Header and antenna for neural stimulation device - patent application Pending 03-Jan-2022
JP-2023549716-A Device and method for remote programming of implanted neurostimulation systems Pending 30-Oct-2020
JP-7072510-B2 External pulse generator devices and related methods for experimental nerve stimulation Active 12-Feb-2016
JP-6928216-B2 Multi-channel clip device and how to use Active 19-Jan-2016 A61N1/36007
To view Axonyx’s complete patent history, request access »

Axonyx Investments & Acquisitions (3)

Axonyx’s most recent deal was a Reverse Merger with TorreyPines Therapeutics. The deal was made on 04-Oct-2006.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
TorreyPines Therapeutics 04-Oct-2006 Reverse Merger Biotechnology
Oxis International 18-Jan-2005 PIPE Pharmaceuticals
Oxis International 20-Jan-2004 Merger/Acquisition Pharmaceuticals
To view Axonyx’s complete investments and acquisitions history, request access »

Axonyx Exits (2)

Axonyx’s most recent exit was on 18-Jan-2005 from Oxis International. The exit was categorized as with 5 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Oxis International 18-Jan-2005 Completed
  • 5 buyers
Oxis International 20-Jan-2004 Merger/Acquisition Completed
To view Axonyx’s complete exits history, request access »

Axonyx FAQs

  • When was Axonyx founded?

    Axonyx was founded in 1997.

  • Where is Axonyx headquartered?

    Axonyx is headquartered in New York, NY.

  • What industry is Axonyx in?

    Axonyx’s primary industry is Drug Discovery.

  • Is Axonyx a private or public company?

    Axonyx is a Private company.

  • What is Axonyx’s current revenue?

    The current revenue for Axonyx is .

  • How much funding has Axonyx raised over time?

    Axonyx has raised $79.3M.

  • When was Axonyx acquired?

    Axonyx was acquired on 04-Oct-2006.

  • Who acquired Axonyx?

    Axonyx was acquired by TorreyPines Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »